Benchmark Holdings, the aquaculture genetics, health and advanced nutrition company, announces that Hugo Wahnish has informed the Board of his intention to resign as a Non-Executive Director of the Company with effect from 9 February 2021.
Benchmark, the aquaculture health, nutrition and genetics business, announces that Malcolm Pye, Benchmark’s founder and Chief Executive Officer, has notified the Board of his decision to step down to allow the Company to appoint a new Chief Executive to drive the next phase of Benchmark’s growth and development.
Benchmark, the aquaculture health, nutrition and genetics business, announces that Mark Plampin will step down from his current role of Chief Financial Officer. Mark will continue in his role until a successor is appointed to ensure an orderly transition process.
Benchmark (LSE:BMK), the aquaculture health, genetics and advanced nutrition business, announces its interim results for the six months ended 31 March 2019.
Benchmark, the aquaculture health, nutrition and genetics business today provides the following trading update and announces that it has mandated DNB Markets to arrange a series of fixed income investor meetings in connection with the refinancing of its existing $90m credit facility.
Benchmark, the aquaculture health, nutrition and genetics business, announces the appointment of Kristian Eikre as Non-Executive Director of the Company which will take effect immediately after the Company’s General Meeting to take place on 14 March 2019.
Benchmark (LSE:BMK), the aquaculture health, advanced nutrition, and genetics business , is pleased to announce an agreement to fund a Chilean breeding and genetics joint venture with Empresas AquaChile S.A.